Family Medicine · Los Angeles, CA
NPI
1144278938
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1701 E Cesar Chavez Ave, Suite 402
Los Angeles, CA, 90033
Phone (323) 317-9200
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$180K
845 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Robert P Krochmal prescribed most often to Medicare patients was Levothyroxine Sodium, with 63 prescriptions and refills. In total Robert P Krochmal wrote 845 Medicare prescriptions that cost $180K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 63 | 189 | 19 | $712 |
| Liothyronine Sodium Generic | 43 | 98 | 13 | $3,224 |
| Progesterone Progesterone, Micronized | 42 | 112 | 12 | $1,528 |
| Synthroid Levothyroxine Sodium | 42 | 87 | Under 11 | $2,783 |
| Zolpidem Tartrate Generic | 23 | 29 | Under 11 | $36.84 |
| Clonazepam Generic | 22 | 31 | Under 11 | $103 |
| Tramadol Hcl Generic | 22 | 24 | Under 11 | $240 |
| Baclofen Generic | 21 | 30 | 11 | $140 |
| Metformin Hcl Generic | 18 | 50 | Under 11 | $280 |
| Hydrocortisone Generic | 18 | 28 | Under 11 | $998 |
| Anastrozole Generic | 18 | 38 | Under 11 | $56.36 |
| Cyclobenzaprine Hcl Generic | 18 | 18 | Under 11 | $40.64 |
| Armour Thyroid Thyroid,pork | 17 | 35 | Under 11 | $1,497 |
| Fluconazole Generic | 16 | 16 | Under 11 | $333 |
| Gabapentin Generic | 15 | 45 | Under 11 | $305 |
Brand drugs: 132 claims; generic drugs: 692 claims; opioid claims: 41.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert P Krochmal were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.